OptiMARK

OptiMARK is a brand name of gadoversetamide, approved by the FDA in the following formulation(s):

OPTIMARK (gadoversetamide - injectable; injection)

• 
  Manufacturer: MALLINCKRODT
  
  Approval date: December 8, 1999
  
  Strength(s): 16.545GM/50ML (330.9MG/ML) ^[RLD], 1654.5MG/5ML (330.9MG/ML) ^[RLD], 3309MG/10ML (330.9MG/ML) ^[RLD], 4963.5MG/15ML (330.9MG/ML) ^[RLD], 6618MG/20ML (330.9MG/ML) ^[RLD]

Has a generic version of OptiMARK been approved?

No. There is currently no therapeutically equivalent version of OptiMARK available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of OptiMARK. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with OptiMARK.

See also...